EP3962942
ANTI-IL-6 ANTIBODY FORMULATION
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
30.4.2020EP published:
22.10.2025EP application number:
20728590.9
EPO information:
European Patent Register
Max expiry date:
29.4.2040
Title in English:
ANTI-IL-6 ANTIBODY FORMULATIONLanguage of the patent:
English
Timeline
Today
30.4.2020EP application
22.10.2025EP Publication
Owner
Name:
Novo Nordisk A/SAddress:
Novo Allé, 2880 Bagsværd, DK
Inventor
Name:
ZHU, GaozhongAddress:
2880 Bagsværd, DK
Name:
SHAHROKH, ZahraAddress:
2880 Bagsværd, DK
Name:
MELVILLE, MarkAddress:
2880 Bagsværd, DK
Name:
DEVALARAJA, Madhav, N.Address:
2880 Bagsværd, DK
Priority
Number:
201962841662 PDate:
1.5.2019Country:
US
Number:
19181345Date:
19.6.2019Country:
EP
Classification
Categories:
C07K 16/24, A61K 39/395, A61K 47/18, A61K 47/26